Anpac Bio Abstract-Evaluation of a Multi-Level, Multi-Parameter Detection Method for Digestive System Cancer Diagnosis
Anpac-Bio-Abstract-Evaluation-of-a-Multi-Level-Multi-Parameter-Detection-Method-for-Digestive-System-Cancer-Diagnosis
Entries by Phil Case
Anpac Bio Abstract-Investigations of a New Diagnostics Technology for Hepatocellular Carcinoma Screening
Anpac-Bio-Abstract-Investigations-of-a-New-Diagnostics-Technology-for-Hepatocellular-Carcinoma-Screening
Anpac Bio Abstract-Investigations of an Improved Esophageal Cancer Diagnostics Approach
Anpac-Bio-Abstract-Investigations-of-an-Improved-Esophageal-Cancer-Diagnostics-Approach
Anpac Bio Abstract-Investigations of Breast Cancer Screening Using a Novel In Vitro Diagnostics Technology
Anpac-Bio-Abstract-Investigations-of-Breast-Cancer-Screening-Using-a-Novel-In-Vitro-Diagnostics-Technology
Anpac Bio Abstract-Investigations on Non-Small Cell Lung Cancer Screening
Anpac-Bio-Abstract-Investigations-on-Non-Small-Cell-Lung-Cancer-Screening
Anpac Bio Abstract-Cancer differentiation analysis technology as a novel technology for cerebral cancer screening.
Cancer-differentiation-analysis-technology-as-a-novel-technology-for-cerebral-cancer-screening
Anpac Bio Launches Major U.S. Expansion, Starting 2nd U.S. Clinical Lab in Philadelphia
Anpac Bio Launches Major U.S. Expansion, Starting 2nd U.S. Clinical Lab in Philadelphia SAN JOSE, California, October 14, 2019 – After winning a major award from the U.S. Department of Commerce as “Minority Health Products and Services Firm of the Year,” and obtaining CLIA certification for its clinical laboratory in San Jose earlier this year, Anpac Bio-Medical Science […]
Anpac Bio Gains U.S. CLIA Lab Certification
AnPac Bio Gains U.S. CLIA Lab Certification SAN JOSE, California, September 26, 2019 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio”), a biotechnology company focusing on early cancer screening and detection, announced that the company’s United States subsidiary, has received a certificate of registration under the U.S. Clinical Laboratory Improvement Amendments of 1988, or CLIA, for its commercial laboratory in San […]
Northwestern’s Dr. Lee Shulman Joins Anpac Bio Technical Advisory Board
SACRAMENTO, Calif., Oct. 23, 2018 — Dr. Chris Yu, Chief Executive Officer of international life sciences corporation, Anpac Bio-Medical Science Company (Anpac Bio), announced today that Northwestern University’s Dr. Lee P. Shulman, MD, FACMG, FACOG, has joined Anpac Bio’s Technical Advisory Board (TAB). It was due to Dr. Shulman’s extensive, award-winning research experience and reputation for identifying innovative solutions to fight disease […]